Candace Kendle, PharmD, 62, a recognized worldwide leader in the CRO industry, co-founded the Company in 1981 and has served as the Company's Chief Executive Officer since its incorporation. Dr. Kendle has been Chairman of the Board since 1991. Since co-founding the Company, she has provided the overall vision, strategy and leadership that has enabled the Company to grow from a small consulting business into one of the largest global CRO's in the industry. She is a founding member and past chairperson of the Association of Clincial Research Organizations (ACRO), which fosters continued advancement of medical product development and expedites the introduction of new medicines and new treatments to improve health and save lives. She is also a member of the Committee of 200, an organization of preeminent women entrepreneurs and corporate leaders and has received numerous civic, financial and pharmaceutical industry leadership awards. Dr. Kendle also serves as a director of the H.J. Heinz Company, a food products manufacturer.

Christopher Bergen co-founded Kendle in 1981 and has served as a Director and Chief Operating Officer since its incorporation in 1997.

As COO, Mr. Bergen is leading our infrastructure expansion to support the company's projected future growth and drive improved global connectivity. Currently he provides leadership for the company's global Enterprise Resource Planning initiative, Project Management Office and Commercial Operations.

Prior to Kendle, Mr. Bergen served in various capacities at The Children's Hospital of Philadelphia, ending his tenure as Associate Vice President.

Robert R. Buck, 61, has served as a director of the Company since June 2003 and formerly served as a director of the Company from 1998 through August 2002. Mr Buck currently serves as Chairman and Chief Executive Officer of Beacon Roofing Supply, Inc., a roofing and building products company. From 1982 through January 2003 he served in a number of management and senior management positions with Cintas Corporation, most recently as President of its Uniform Rental Division. He serves as a director of Multi-Color Corporation, a provider of decorating solutions and packaging services and LVI Services, an environmental remediation provider.

G. Steven Geis, PhD, MD, has served as a director of Kendle since November 2002. Now retired, Dr. Geis served in a number of management and senior management positions with Searle and the Pharmacia Companies from 1985 to July 2002. He most recently served as Group Vice President: Arthritis, Cardiovascular and Oncology Clinical Development from March 2001 through July 2002 and Vice President: Arthritis Clinical Development from August 1998 through March 2001. He has authored or co-authored numerous journal articles covering several therapeutic areas.

Donald C. Harrison, MD,has served as a director of Kendle since November 2001. He is Senior Vice President and Provost for Health Affairs Emeritus at University of Cincinnati. Dr. Harrison formerly served as the Senior Vice President and Provost for Health Affairs at University of Cincinnati from 1986 through 2003 and also served as the Chief Executive Officer of the University of Cincinnati Medical Center. He also is a practicing cardiologist on a part-time basis. Dr. Harrison's professional experience includes 24 years at Stanford University School of Medicine and Stanford University Hospital, where he was Chief of Cardiology from 1967 to 1968. He is past national President of the American Heart Association and has served as a director for several not-for-profit organizations. Dr. Harrison also serves as a director for start-up medical device and biotechnology companies, including UMD, Inc., Medical Education and Consultation Inc.; AtriCure, Inc.; and EnteroMedics, Inc. Since 2004, he has been a general partner in Charter Life Sciences, a California-based venture capital firm, for which he manages the Cincinnati office.

Timothy E. Johnson, PhD., 66, has served as a director of the Company since November 2002. Dr. Johnson is a financial and investment consultant and has served as President of Johnson Investment Counsel, Inc. since 1965. Johnson Investment Counsel, Inc. is a registered investment adviser and manages portfolio assets for endowments, foundations, corporations, individuals and pension and profit sharing plans. He also serves as a Professor of Finance at the University of Cincinnati, where he has taught since 1970. He serves as a director or trustee for several civic and nonprofit organizations. He has written several textbooks and articles on investment and financial management.

Timothy M. Mooney was reappointed to Kendle's board in November 2008. Mr. Mooney previously served as a director from 1997 through 2002. He also served as Executive Vice President and Chief Financial Officer of Kendle from 1996 through 2002, leading the Company's global financial operations, including finance, accounting, treasury, budgeting, taxes, mergers and acquisitions, investor relations and financial planning. Mr. Mooney currently serves as Vice President of Operations at St. Xavier High School in Cincinnati.

Frederick A. Russ, PH.D., 64, has served as a director of the Company since November 2002. Dr. Russ is currently Professor of Marketing at the University of Cincinnati. He previously served as the Senior Vice Provost for the University of Cincinnati from October 2004 until 2007. From 1994 through September 2004, he was Dean of the College of Business there. He also serves on the Board of Directors of Charles & Colvard, Ltd., a manufacturer and supplier of specialty jewelry and formerly served as its non-executive Chairman of the Board. His professional experience also includes 18 years at the University of North Carolina, membership on the founding Board of Directors of Cree Inc., an advanced materials company and consulting in marketing and marketing research to a wide variety of organizations. He as co-authored three textbooks and has written numerous articles on marketing strategy and the behavior of consumers and sales personnel.